Report overview
This report contains market size and forecasts of Pravastatin Sodium API in global, including the following market information:
Global Pravastatin Sodium API Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Pravastatin Sodium API Market Sales, 2018-2023, 2023-2030, (Tons)
Global top five Pravastatin Sodium API companies in 2022 (%)
The global Pravastatin Sodium API market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
0.98 Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Pravastatin Sodium API include Hunan Huateng Pharmaceutical, Chongqing DaXin Pharmaceutical, Guangdong Blue Treasure Pharmaceutical, Livzon Group Fuzhou Fuxing Pharmaceutical, Zhejiang Hisun Pharmaceutical, Teva API, Apotex Pharmachem, Concord Biotech and DEAFARMA, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Pravastatin Sodium API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pravastatin Sodium API Market, by Purity, 2018-2023, 2023-2030 ($ Millions) & (Tons)
Global Pravastatin Sodium API Market Segment Percentages, by Purity, 2022 (%)
0.98
0.99
0.995
Others
Global Pravastatin Sodium API Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (Tons)
Global Pravastatin Sodium API Market Segment Percentages, by Application, 2022 (%)
Tablets
Capsules
Others
Global Pravastatin Sodium API Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (Tons)
Global Pravastatin Sodium API Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pravastatin Sodium API revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Pravastatin Sodium API revenues share in global market, 2022 (%)
Key companies Pravastatin Sodium API sales in global market, 2018-2023 (Estimated), (Tons)
Key companies Pravastatin Sodium API sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hunan Huateng Pharmaceutical
Chongqing DaXin Pharmaceutical
Guangdong Blue Treasure Pharmaceutical
Livzon Group Fuzhou Fuxing Pharmaceutical
Zhejiang Hisun Pharmaceutical
Teva API
Apotex Pharmachem
Concord Biotech
DEAFARMA
Daiichi Sankyo
Kyowa Hakko Bio
Lek Pharmaceuticals
RANBAXY LABORATORIES LIMITED
Vitalpharms
Tocopharm
